Report Details:
15 Companies Covered
100 Pages
Cerebral Oximetry Monitoring Market Highlights
The Global Cerebral Oximetry Monitoring Market size was valued at USD 289.50 Million in 2025, and the market is projected to grow from USD 313.67 Million in 2026 to USD 645.50 Million by 2035, registering a CAGR of 8.35% during the forecast period 2026–2035.
Cerebral oximetry is a simple, non-invasive monitoring procedure used in a variety of different clinical applications such as cardiac and vascular surgeries; the technology is evolving and expected to be applicable beyond cardiac surgery.
The market for cerebral oximetry monitoring is anticipated to grow at a steady pace, the major factors influencing the growth of the market include; technological advancement in the field of medical devices, increasing demand for non-invasive procedures, increasing penetration of non-invasive devices in surgical procedures, increasing government programs for the safety of the newborn. However, few limitations such as low measurement, the accuracy of measurement, and limited measurement of regional cerebral oxygenation hamper the growth of the market.
Regional Analysis
Geographically the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The Americas is anticipated to dominate the global cerebral oximetry monitoring market owing to the presence of major manufacturers in the region, favorable reimbursement scenario, increasing demand for non-invasive procedures, increasing technological advancement in the region, and increasing R&D expenses.
The European cerebral oximetry monitoring market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
Europe is expected to hold the second largest position in the global cerebral oximetry monitoring market. The market growth in this region is attributed to the increasing government programs for the safety of newborn in countries such as the UK, Germany, and France.
The cerebral oximetry monitoring market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cerebral oximetry monitoring market in the Middle East & Africa has been segmented into the Middle East and Africa. The Asia-Pacific region is expected to be the fastest growing region owing to the increasing healthcare development in developing countries.
The Middle East & Africa has the least share of the market and expected to grow at a steady pace due to changing healthcare structure.
Segmentation
The global cerebral oximetry monitoring market has been segmented into age, application and end user.
Based on age, market segmented into adults and pediatrics. The adults segment is expected to account for the largest share segment of the market in 2025 due to the increasing number of cardiac in the adults.
Based on Application, cerebral oximetry monitoring market is segmented into cardiac surgery (Coronary artery bypass surgery, Deep hypothermic circulatory arrest), vascular surgery (carotid endarterectomy, carotid endarterectomy hyperperfusion syndrome), and pediatrics.
Based on end user, the cerebral oximetry monitoring market segmented into hospitals, clinics, ambulatory surgical centers, and others.
Key Players
Some of the prominent players in the global cerebral oximetry monitoring market are Medtronic, Philips Healthcare, Masimo, GE Healthcare, Edwards Lifesciences, Mindray Medical, Natus Medical, Honeywell Life Sciences, Welch Allyn, Omron Healthcare, Boston Scientific.
